| 908 |
Centers for Disease Control and Prevention |
Html |
en |
Notifiable Diseases and Mortality Tables |
Table I Summary of provisional cases of selected notifiable diseases, United States, cumulative, week ending February 1, 2014 (5th Week). |
| different event codes | 0.546801 |
| H. influenzae | 0.452363 |
| CDC | 0.414052 |
| California serogroup | 0.55608 |
| age group | 0.387684 |
| novel influenza | 0.703217 |
| invasive pneumococcal disease | 0.892885 |
| eastern equine | 0.380257 |
| measles cases | 0.488963 |
| ** Data | 0.425291 |
| western equine diseases | 0.534069 |
| case notifications | 0.390439 |
| susceptible cases | 0.444658 |
| probable cases | 0.461634 |
| Rocky Mountain | 0.373758 |
| rickettsia infections | 0.425981 |
| ArboNET Surveillance | 0.380001 |
| Zoonotic | 0.241021 |
| rubella cases | 0.457909 |
| Spotted fever rickettsioses | 0.610947 |
| St. Louis | 0.383265 |
| E. coli | 0.385299 |
| influenza A virus | 0.548185 |
| virus infections | 0.44249 |
|
| National Center | 0.576427 |
| Immunization | 0.238697 |
| cases | 0.716494 |
| pneumoniae invasive disease | 0.605104 |
| Table | 0.294832 |
| Total case counts | 0.562767 |
| Spotted fever group | 0.60869 |
| serogroup non-O157 | 0.555819 |
| serotypes | 0.23788 |
| Shiga | 0.291467 |
| similar clinical presentation | 0.533031 |
| Vector-Borne Infectious Diseases | 0.573027 |
| meningococcal disease | 0.401093 |
| Cumulative total E. | 0.561785 |
| condition | 0.258155 |
| Influenza Division | 0.512298 |
| Streptococcus | 0.243131 |
| unknown serogroup | 0.556482 |
| Respiratory Diseases | 0.40228 |
| Powassan | 0.245724 |
| ages | 0.237911 |
| Enteric Diseases | 0.39817 |
| Includes drug resistant | 0.552698 |
|
CLICK HERE |
| 1242 |
Centers for Disease Control and Prevention |
Html |
en |
Pedestrian Traffic Deaths Among Residents, Visitors, andHomeless Persons - Clark County, Nevada, 2008-2011 |
Kaci L. Hickox, MSN, MPH1,2, Nancy Williams, MD2, Laurie F. Beck, MPH3, Tom Coleman, MD2, John Fudenberg4, Byron Robinson, PhD5, John Middaugh, MD2 (Author affiliations at end of text). |
| Kaci L. Hickox | 0.429115 |
| death certificate data | 0.548114 |
| Las Vegas Boulevard | 0.418314 |
| state census data | 0.379149 |
| homeless pedestrians | 0.412446 |
| visitor pedestrian deaths | 0.569145 |
| pedestrian behavior | 0.438084 |
| pedestrian blood alcohol | 0.502157 |
| pedestrian traffic death | 0.528652 |
| homeless shelter curfews | 0.416493 |
| motor vehicle collisions | 0.540631 |
| Las Vegas | 0.478476 |
| homeless decedent | 0.390515 |
| Homeless pedestrian death | 0.567747 |
| pedestrian death rates | 0.844848 |
| higher pedestrian death | 0.487981 |
| homeless pedestrian deaths | 0.619278 |
| injury deaths | 0.391177 |
| visitors | 0.401619 |
| Clark County residents | 0.410846 |
| homeless persons | 0.932153 |
| Nevada residents | 0.376912 |
| Southern Nevada Health | 0.377119 |
| higher death rates | 0.389497 |
| residents | 0.427677 |
|
| pedestrian deaths | 0.897101 |
| homeless census surveys | 0.475074 |
| pedestrian alcohol impairment | 0.465261 |
| Clark County Office | 0.401399 |
| pedestrian signals | 0.433088 |
| resident pedestrian death | 0.548081 |
| greater pedestrian traffic | 0.493273 |
| Nevada Health District | 0.42467 |
| unsheltered homeless population | 0.421139 |
| collision sites | 0.455687 |
| pedestrian refuge islands | 0.457512 |
| Clark County death | 0.419067 |
| Homeless service providers | 0.412977 |
| motor vehicle deaths | 0.432863 |
| homeless census survey | 0.432102 |
| group–specific death rates | 0.396379 |
| Clark County | 0.83031 |
| office data | 0.465251 |
| death certificate race/ethnicity | 0.38408 |
| pedestrian exposure | 0.433699 |
| pedestrian traffic deaths | 0.654768 |
| unsheltered homeless persons | 0.477833 |
| Annual resident pedestrian | 0.483165 |
| visitor pedestrian death | 0.480701 |
|
CLICK HERE |
| 4874 |
Centers for Disease Control and Prevention |
Html |
en |
PPE: Trainer's Information- HAI |
null |
| training healthcare personnel | 0.632019 |
| web application | 0.558002 |
| biggest challenge | 0.550595 |
| Expanded Precautions | 0.554302 |
| ~12th grade language | 0.601919 |
| staff development | 0.564659 |
| PPE terminology | 0.795581 |
| proper PPE donning/removal | 0.829788 |
| larger group | 0.551522 |
| Presentation Time | 0.559993 |
| biggest mistakes | 0.550666 |
| slide set | 0.681877 |
| person act | 0.548285 |
| healthcare worker | 0.609133 |
| personal protective equipment | 0.708179 |
| microbiological hazards | 0.563425 |
| time permits | 0.551303 |
| safe practices | 0.558172 |
| patient scenarios | 0.55069 |
| particular healthcare setting | 0.610086 |
| healthcare personnel | 0.652985 |
| audience needs | 0.624961 |
| Flip chart | 0.553 |
| PPE | 0.970147 |
| maintenance workers | 0.555444 |
|
| adult learning | 0.562122 |
| infection control | 0.563056 |
| training materials | 0.563264 |
| PPE return demonstration | 0.856122 |
| target audience | 0.566554 |
| PPE demonstration | 0.815832 |
| healthcare | 0.653966 |
| team member | 0.550876 |
| proper PPE | 0.846819 |
| interactive presentation | 0.559854 |
| Didactic presentation | 0.574026 |
| following questions | 0.550674 |
| healthcare audience | 0.584688 |
| worldwide outbreak | 0.564529 |
| small groups | 0.551563 |
| ancillary personnel | 0.557978 |
| healthcare setting | 0.615818 |
| healthcare workers | 0.560924 |
| healthcare work environment | 0.619932 |
| individual self-study | 0.558162 |
| entire program | 0.549721 |
| healthcare settings | 0.607964 |
| respirator training | 0.55526 |
| occupational health personnel | 0.617449 |
|
CLICK HERE |
| 5366 |
Centers for Disease Control and Prevention |
Html |
en |
Intradermal Influenza (Flu) Vaccination |
Intradermal Influenza (Flu) Vaccination - CDC |
| Seasonal Flu Vaccine | 0.466155 |
| intradermal flu shot | 0.345822 |
| flu vaccines | 0.340371 |
| regular flu shot | 0.787398 |
| flu viruses | 0.334008 |
| intradermal flu vaccine | 0.983501 |
|
| intradermal vaccine | 0.511535 |
| regular flu shots | 0.40784 |
| Fluzone flu shot | 0.370245 |
| quadrivalent flu vaccines | 0.32177 |
| Fluzone Intradermal vaccine | 0.301265 |
|
CLICK HERE |
| 6116 |
Centers for Disease Control and Prevention |
Html |
en |
Silica - crystalline (as respirable dust) - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6845 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Preventing Chronic Disease: Volume 9, 2012: 11_0196 |
Public access defibrillation (PAD) policies have been enacted to create programs that increase the public availability of these devices. The objective of this study was to describe each state’s legal requirements for recommended PAD program elements. |
| PAD program elements | 0.737354 |
| common PAD element | 0.32298 |
| PAD programs | 0.867593 |
| out-of-hospital cardiac arrest | 0.552995 |
| state PAD laws | 0.374526 |
| survival rates | 0.315862 |
| comprehensive PAD | 0.353366 |
| PAD program facilitators | 0.354551 |
| emergency response plan | 0.296881 |
| common PAD elements | 0.350526 |
| AED placement | 0.332958 |
| targeted AED placement | 0.316938 |
| quality improvement | 0.356667 |
| extent PAD policies | 0.319532 |
| civil immunity | 0.325044 |
| jurisdictions | 0.503555 |
| additional PAD elements | 0.339675 |
| PAD medical directors | 0.324463 |
| AED | 0.51896 |
| PAD elements | 0.476901 |
| sudden cardiac arrest | 0.303638 |
| emergency response | 0.348718 |
| PAD program facilitator | 0.367992 |
| cardiac arrest | 0.906151 |
|
| American Heart Association | 0.460722 |
| comprehensive PAD legislation | 0.307576 |
| fewer PAD elements | 0.349377 |
| PAD maintenance | 0.32594 |
| public access defibrillation | 0.611637 |
| PAD program element | 0.345998 |
| existing PAD programs | 0.33919 |
| medical emergency response | 0.306084 |
| AED device | 0.317124 |
| AEDs | 0.375556 |
| external defibrillator | 0.350481 |
| cardiac arrest survival | 0.337233 |
| AED sites | 0.337613 |
| effective PAD policies | 0.401237 |
| emergency medical service | 0.309832 |
| select AED sites | 0.314109 |
| recommended PAD program | 0.489388 |
| PAD policies | 0.50489 |
| rescuer PAD programs | 0.422643 |
| comprehensive PAD policies | 0.348451 |
| continuous quality improvement | 0.338198 |
| comprehensive PAD policy | 0.332778 |
| mandatory PAD registries | 0.389743 |
| AED users | 0.337134 |
|
CLICK HERE |
| 7509 |
Centers for Disease Control and Prevention |
Html |
en |
Perchlorate Fact Sheet October 5, 2006 |
Data Resources for the National Center for Environmental Health |
| thyroid hormone | 0.84512 |
| micrograms | 0.435435 |
| thyroid hormone lead | 0.683566 |
| thyroid hormone levels | 0.75181 |
| body’s metabolism | 0.493597 |
| thyroid stimulating hormone | 0.703655 |
| good source | 0.48783 |
| perchlorate exposure | 0.85389 |
| human activity | 0.485713 |
| widespread presence | 0.483762 |
| Perchlorate Ingestion | 0.811389 |
| small-to-moderate size changes | 0.582611 |
| previous studies | 0.50412 |
| statistically significant association | 0.570335 |
| U.S. Food | 0.480177 |
| perchlorate | 0.998751 |
| journal Environmental Health | 0.566812 |
| iodized salt | 0.50291 |
| lower iodine levels | 0.829021 |
| TSH levels | 0.520416 |
| thyroid function | 0.756905 |
| chemical | 0.430922 |
| urine iodine levels | 0.80417 |
| Environmental Protection Agency | 0.552412 |
| similar association | 0.495401 |
|
| health effects | 0.487463 |
| women | 0.554648 |
| thyroxine levels | 0.535481 |
| study | 0.512983 |
| good thyroid health | 0.654237 |
| United States | 0.494138 |
| thyroid gland | 0.644398 |
| Drug Administration | 0.483372 |
| natural sources | 0.483737 |
| sufficient intake | 0.494159 |
| lower iodine intake | 0.738196 |
| Health Implications | 0.484683 |
| dietary iodine | 0.627862 |
| relationship | 0.451719 |
| low-dose exposure | 0.496004 |
| People | 0.430798 |
| CDC researchers | 0.505069 |
| U.S. population | 0.500339 |
| teaspoon | 0.421173 |
| µg/L). | 0.505234 |
| higher levels | 0.507707 |
| Perchlorate Questions | 0.79626 |
| thyroid hormones | 0.586227 |
| rocket fuel | 0.484995 |
|
CLICK HERE |
| 9041 |
Centers for Disease Control and Prevention |
Html |
en |
Bed Bugs - Global Health |
Education and information about bed bugs including frequently asked questions, biology and publications. |
| bed bugs | 0.743467 |
| list Skip | 0.65359 |
| page options Skip | 0.9066 |
| best way | 0.275386 |
|
| problem worldwide | 0.288354 |
| property loss | 0.285205 |
| navigation Skip | 0.669043 |
| regular inspection | 0.272241 |
|
CLICK HERE |
| 9195 |
Centers for Disease Control and Prevention |
Html |
en |
Visiting Friends or Relatives Overseas | CDC Features |
People who are traveling to a foreign country to visit friends or relatives (VFR travelers) are at a higher risk for some diseases. If you are a VFR traveler, consider your risk and plan appropriately. |
| instructions | 0.410765 |
| limited time | 0.45513 |
| VFR traveler | 0.535506 |
| malaria medicine | 0.469814 |
| trip | 0.410111 |
| people’s homes | 0.455089 |
| foodborne illnesses | 0.451881 |
| plan | 0.424707 |
| bug bites | 0.455183 |
| mosquitoes | 0.411119 |
| malaria-prevention medicine | 0.452676 |
| VFR travelers | 0.947869 |
| tuberculosis | 0.410532 |
| malaria pills | 0.472867 |
| pressure | 0.410267 |
| relatives | 0.488555 |
| friends | 0.491678 |
| sexually transmitted diseases | 0.491764 |
| consultation | 0.410012 |
| local bacteria | 0.449659 |
| room temperature | 0.449376 |
| local food | 0.452332 |
| United States | 0.608325 |
| vaccines | 0.441543 |
| precautions | 0.411421 |
|
| typhoid | 0.411002 |
| professionals | 0.41207 |
| immunity | 0.426081 |
| malaria | 0.504432 |
| foreign country | 0.51375 |
| customized advice | 0.449643 |
| harmful substances | 0.45377 |
| swimming | 0.409988 |
| times | 0.411039 |
| long time | 0.453591 |
| travel medicine specialist | 0.488157 |
| higher risk | 0.511365 |
| active ingredients | 0.453039 |
| bug spray | 0.448424 |
| cost | 0.411221 |
| health considerations | 0.452371 |
| dengue | 0.411637 |
| counterfeit medicines | 0.45438 |
| doctor | 0.436962 |
| raw fruits | 0.449822 |
| parasites | 0.410205 |
| language barriers | 0.457516 |
| tourists | 0.440657 |
| family | 0.410251 |
|
CLICK HERE |
| 14087 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Guideline for Prescribing Opioids for Chronic Pain |
null |
| patient-centered clinical practices | 0.618226 |
| specific recommendations | 0.529171 |
| chronic pain | 0.956601 |
| access | 0.445824 |
| abuse | 0.423454 |
| death | 0.420962 |
| previous guidelines | 0.577038 |
| recommendations | 0.538911 |
| palliative care | 0.522152 |
| CDC Guideline | 0.847976 |
| Higher doses | 0.523247 |
| number | 0.423499 |
| Prescribing Opioids | 0.748205 |
| thorough assessments | 0.514405 |
| harms | 0.42362 |
| prescription opioids | 0.721121 |
| high risk patients | 0.604782 |
| monitoring programs | 0.50897 |
| chronic pain treatment | 0.871437 |
| morphine milligram equivalents | 0.626399 |
| effective chronic pain | 0.879489 |
| higher risk | 0.512069 |
|
| possible treatments | 0.517125 |
| relatively low doses | 0.619428 |
| dosage recommendations | 0.533729 |
| normal tissue | 0.520023 |
| available tools | 0.509996 |
| primary care settings | 0.636847 |
| active cancer treatment | 0.621605 |
| people | 0.423484 |
| way opioids | 0.861295 |
| pose risk | 0.514303 |
| opioid pain medication | 0.749572 |
| opioid use disorder | 0.687616 |
| clinical practice guidelines | 0.833487 |
| state prescription drug | 0.60825 |
| opioid prescribing guidelines | 0.668338 |
| risks | 0.443416 |
| main focus areas | 0.607812 |
| recent technological advances | 0.60256 |
| safety precautions | 0.512206 |
| time | 0.421505 |
| opioids | 0.953348 |
| end-of-life care | 0.525262 |
|
CLICK HERE |